National Health Council Praises Passage of the 21st Century Cures Act

National Health Council Praises Passage of the 21st Century Cures Act

Washington, DC (December 7, 2016) – The National Health Council (NHC) publicly thanked Congress for its passage of the 21st Century Cures Act and urged President Obama to sign the legislation into law.

The following statement is from NHC’s Chief Executive Officer, Marc Boutin:

“Today is a tremendous day for people with chronic diseases and disabilities who are desperately awaiting better treatments and cures. The passage of the 21st Century Cures Act by an overwhelming majority of Representatives and Senators is the culmination of years of hard work and negotiation to develop a truly non-partisan piece of legislation. In particular, I thank Representatives Fred Upton (R-MI), Diana DeGette (D-CO), and Frank Pallone (D-NJ) and Senators Lamar Alexander (R-TN) and Patty Murray (D-WA) for their tireless dedication and leadership on this bill, and I urge President Obama to sign this bill as soon as possible.

“Once this bill is signed into law, it will increase investment in biomedical research. It will also strengthen the voice of patients in the development of medical products, allow researchers and the Food and Drug Administration to use 21st century tools for research and evaluation, and ultimately bring new and better medicines and devices to patients in a more timely fashion.”

Founded in 1920, the NHC is the only organization that brings together all segments of the health community to provide a united voice for the more than 133 million people with chronic diseases and disabilities and their family caregivers. Made up of more than 100 national health-related organizations and businesses, the NHC's core membership includes the nation’s leading patient advocacy organizations, which control its governance and policy-making process. Other members include professional and membership associations, nonprofit organizations with an interest in health, and representatives from the pharmaceutical, generic drug, insurance, medical device, and biotechnology industries.

Additional Information:

·Letter from over 200 patient advocacy organizations, urging passage of the 21st Century Cures Act by the end of 2016: http://www.nationalhealthcouncil.org/sites/default/files/2016_21_Century_Cures_Sign_On_Letter.pdf

Contact:
Rachel Stivers
rstivers@nhcouncil.org
202-973-0547